Table of Contents
Table of Contents
Preface
Chapter 1. Beta-Blockers for Heart Failure: Pharmacology, Relevance, and Justification
(Shahid Akbar and John R. Richards, Medical University of the Americas, Nevis, West Indies, and others)
Chapter 2. Beta-Blockers for Control of Hypertension: Controversy, Evidence, and Current Practice
(Shahid Akbar and John R. Richards, Medical University of the Americas, Nevis, West Indies, and others)
Chapter 3. Beta-Blockers in Critical Care and Obstructive Lung Diseases: New Directions
(Brooks T. Kuhn, E. Pierce Stewart, Mark V. Avdalovic, Timothy E. Albertson, and Michael Schivo, Department of Internal Medicine, University of California, Davis, Medical Center, Sacramento, California, and others)
Chapter 4. Beta-Blockers Following Traumatic Injury
(Tyler J. Loftus, Elizabeth S. Miller, and Alicia M. Mohr, Department of Surgery and Sepsis and Critical Illness Research Center, University of Florida, Gainesville, Florida, USA)
Chapter 5. Beta-Blocker Overdose: Progressive Treatment Options
(Timothy. E. Albertson, Alyrene A. Dorey, John R. Richards, and Susan Murin, Department of Internal Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, University of California, Davis School of Medicine, Sacramento, California, USA, and others)
Chapter 6. Beta-Blockade in Septic Shock: A Paradigm Shift in Management?
(Richard Browne and Tony Whitehouse, Department of Critical Care and Anaesthesia, Queen Elizabeth Hospital, Birmingham, United Kingdom)
Chapter 7. The Unopposed Alpha-Stimulation Phenomenon: What is the Role of Beta-Blockers?
(John R. Richards, Howard E. McKinney Jr, and Bernard Silke, Department of Emergency Medicine, University of California, Davis School of Medicine, Sacramento, California, USA, and others)
Chapter 8. Beta-Blockers and Cancer: An Emerging Treatment
(Shahid Akbar and John R. Richards, Medical University of the Americas, Nevis, West Indies, and others)
Chapter 9. The Use of Beta-Blockers in the Emergency Department
(Max Hockstein and Deborah Diercks, Department of Emergency Medicine, University of Texas Southwestern, Dallas, Texas, USA)
Chapter 10. Beta-Adrenergic Blockade in Patients with Myocardial Infarction: Evolution, Efficacy and Controversy
(Ezra A. Amsterdam, Shahad Al Chalaby, Sean Fraser, Naveen Gupta, Tina Gupta, Muhammad Majid, Balasingam Thevakumar, Navya Sree Vipparla, and Sandhya Venugopal, Division of Cardiovascular Medicine, Department of Internal Medicine, University of California, Davis School of Medicine, Sacramento, California, USA)
Chapter 11. Beta-Blocker Therapy for Acute Coronary Syndrome and Stable Coronary Artery Disease: Current Issues and Outcomes
(Manoj Kesarwani, Division of Cardiovascular Medicine, Department of Internal Medicine, University of California, Davis School of Medicine, Sacramento, California, USA, and others)
Index
Keywords: Beta-blocker, β-blocker, heart failure, hypertension, sepsis, cocaine, methamphetamine, unopposed alpha, unopposed α, stimulant toxicity, thyrotoxicosis, obstructive lung disease, trauma, pheochromocytoma, cancer, acute coronary syndromes, and coronary arterial disease
This book will be of interest to physicians, pharmacists, nurse practitioners, physician assistants, nurses, research scientists, and informed patients.
